Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alamar Biosciences, Inc.ALMR · Entity 1791 | General Counsel | September 14, 2026 | September 16, 2026 |
| Outset Medical, Inc.OM · Entity 7026 | General Counsel | August 17, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alamar Biosciences, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,000 |
Reported balance
After 2026-09-14 transaction · row 1
1 source rowRow 1 · 2026-09-14 · Grant · Acquired 29,000 · Balance 29,000 F1: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.99 · Expires 2036-09-13 | Direct | 85,000 |
Reported balance
After 2026-09-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-14 · Grant · Acquired 85,000 · Balance 85,000 F2: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
F2: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
Outset Medical, Inc.
Report date August 17, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,475 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Sale · Disposed 2,632 · Balance 87,475 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2021 Filed Mar 18, 2021 01:11 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 11,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-008972 · form4.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on March 15, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 25% on March 15, 2022, and then quarterly over three years, subject to the reporting person's continuous service through the applicable vesting date. F2 · balance_after: Includes 1,003 shares acquired under the Outset Medical Inc. Employee Stock Purchase Plan on February 28, 2021. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 18:50 UTC Amendment | Outset Medical, Inc. OM · Entity 7026 | GrantStock Option (Right to Buy) · Derivative | 22,209 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001140361-21-009045 · form4.xml · derivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,209 Underlying: Common Stock · 22,209 shares Expires 2031-03-14 F2 · derivative.exercise_price: This Form 4 amendment is being filed to correct the exercise price. F1 · derivative.exercise_date: This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:25 UTC | Outset Medical, Inc. OM · Entity 7026 | PurchaseCommon Stock | 2,500 | $27.00 | $67,500.00 |
DisclosureSEC source: 0001140361-20-020798 · form4.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| May 26, 2020 Filed Sep 18, 2020 00:25 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantPerformance Stock Option (Right to Buy) · Derivative | 45,265 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001140361-20-020798 · form4.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,265 Underlying: Common Stock · 45,265 shares Expires 2030-05-26 F3 · derivative.exercise_price: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020. F4 · kind: This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. F3 · shares: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020. F2 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lock-up period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. F3 · derivative.underlying_shares: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020. F3 · balance_after: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020. Read SEC document |
| May 26, 2020 Filed Sep 18, 2020 00:25 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantStock Option (Right to Buy) · Derivative | 67,898 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001140361-20-020798 · form4.xml · derivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,898 Underlying: Common Stock · 67,898 shares Expires 2030-05-26 F3 · derivative.exercise_price: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020. F4 · kind: This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. F3 · shares: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020. F1 · derivative.exercise_date: This option vests 25% on May 26, 2021, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. F3 · derivative.underlying_shares: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020. F3 · balance_after: This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.